跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
[68Ga]PSMA
首页
药物
[68Ga]PSMA
[68Ga]PSMA
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AS DIAGNOSTIC AND RADIONUCLIDE THERAPEUTIC AGENTS
EP 3958916 A1
申请人: FIVE ELEVEN PHARMA INC
优先权: 2019
CN
EP
US
WO
4 件公开
METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS
US 2023330278 A1
申请人: NOVARTIS AG
优先权: 2020
CN
EP
US
WO
4 件公开
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
US 10688200 B2
申请人: FIVE ELEVEN PHARMA INC
优先权: 2015
CN
US
2 件公开
METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS
US 2023165980 A1
申请人: NOVARTIS AG
优先权: 2020
CN
US
2 件公开
PSMA-TARGETING RADIOACTIVE METAL COMPLEX CONTAINING NITRO AROMATIC HETEROCYCLIC GROUP AND PREPARATION THEREOF
WO 2023231452 A1
申请人: UNIV BEIJING NORMAL
优先权: 2023
CN
WO
2 件公开
COMPOUND FOR DUAL TARGETING OF TUMOR CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF
WO 2025151982 A1
申请人: PEKING UNION MEDICAL COLLEGE HOSPITAL CAMS
优先权: 2024
CN
WO
2 件公开
68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents
US 10717750 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2016
US
Prostate-specific antigen targeting inhibitor of nuclide marker and preparation method of nuclide marker
CN 106075484 A
申请人: BEIJING CANCER HOSPITAL
优先权: 2016
CN
2-alkoxy-6-[18F]fluoronicotinoyl substituted lys-c(O)-glu derivatives as efficient probes for imaging of PSMA expressing tissues
US 11542234 B2
申请人: UNIV KOELN
优先权: 2018
US
前列腺癌PET诊断试剂68Ga-DOTA-ANCP-PSMA及其制备方法和应用
CN 110305186 B
申请人: 原子高科股份有限公司
优先权: 2019
CN
第 1 / 3 页
上一页
下一页
药物
反馈